NS
Namrata Shrimali
About Namrata Shrimali
Data last updated:
Namrata Shrimali is a Director at Oxymune Therapeutics Private Limited (since 2024). The companies operate in Paper. Earlier, Namrata Shrimali was a Designated Partner at Vacmed Biotech Llp (2023–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Oxymune Therapeutics Private Limited U21000MP2024PTC072960 | Director | 23 Sep 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Vacmed Biotech Llp ACD-4187 | Designated Partner | 16 Oct 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Namrata Shrimali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Shrimali | 10784463 | Oxymune Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Namrata Shrimali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namrata Shrimali
Namrata Shrimali currently holds 1 directorship: Oxymune Therapeutics Private Limited (Director, since 23 Sep 2024).
Namrata Shrimali was first appointed on 16 Oct 2023 as Designated Partner at Vacmed Biotech Llp. The most recent appointment on record is 23 Sep 2024 at Oxymune Therapeutics Private Limited.
Namrata Shrimali held 1 earlier board appointment: Vacmed Biotech Llp (Designated Partner, 16 Oct 2023 to 27 Sep 2025).
The current boards of Namrata Shrimali's companies include Deepak Shrimali (Oxymune Therapeutics Private Limited).